Consuetudo PeptideSynthesisService
Hangzhou Top Peptide Biotech in MMXIV statutum est a Nationalibus summus tech Enterprisepraesertim in investigatione, evolutione et productione peptidum et derivatorum affinium.
Societatem'speptide investigationis centrumest currently sita in Qiantang Districtof Hangzhou, area plus quam 3,000 metra quadrata tegens.Thesocietas's officinam sita ad No.24, Haitian Road, Shangyu dolor, Shaoxing urbem, Zhejiang provincia.Sunt etiam Duo cooperante plantisunum est forcommercial peptide GMP fabrica sita in *Anji comitatum Zhejiang provinciaeunum est pro parva moleculae API sita inYuncheng civitas Shanxi provinciae.Facti sumusres alta tech comprehensiveInvestigationes integrantes, gubernator scalarum, mercaturae et venditio globalis.
Comitatu hassuper "100conductos,et habetdeveloped plus40 perfectum pharmaceuticalpeptides;plus quamX invention patentsauctoritate fuisse.Tet annua facultatem productiois usque ad100 chiliogrammatanumerus consuetudinis peptides has pervenit super 20000.Unum-stium peptidis operas ex investigationis (medicamento) ad mercaturam (KGs) praebere possumus.
Peptide Modificatione List
N-terminatio modificationes
| {N-Me-Ala} | {N-Me-Asp} | {N-Me-Glu} | {N-Me-Ile} |
| {N-Me-Leu} | {N-Me-Met} | {N-Me-Nle} | {N-Me-Nva} |
| {N-Me-Phe} | {N-Me-Ser} | {N-Me-Thr} | {N-Me-Tyr} |
| {N-Me-Val} | {Sar} | N-Me-Arg | N-Me-Asn |
| N-Me-beta-Ala | N-Me-Gln | N-Me-Lys | N-Me-Trp |
C-terminatio modificationes
| {Mono disulfide pontis} | {Pontem Duplex Disulfide} | {Triplex pons Disulfide} |
| {Random Disulfide pontem} | Idem {Seq.Inter-Disulfide pontis } | {Pont} Diversus Inter-Disulfide |
| Amde cyclica}. | {Amide cyclica (cathena lateralis)} | {Orn latus catena Amide cyclica} |
| {Thioester cyclicus} | {lactone cyclica} | {Sec cyclica} |
amino acida insolitus
| {2-Aze} | {3-Aze} | {5,5-Dime-Pro} |
| {5-ASA} | {Abu} | {Ac-Lys} |
| {Aib} | {Beta-Asp} | {Bpa} |
| {Cha} | {Chg} | {cit} |
| {Cpg} | {Cys(Acm)} | {Cys(Bzl)} |
Isotope intitulatum peptides
| Lys (13C6,15N2) | Ile (13C6,15N) |
| Leu (13C6,15N) | Val (13C5, 15N) |
| Arg (13C6, 15N4). |
Fluorescent peptide modificationes / FRETO pairs
| Biotin- | Dansyl- | Restinctus fluorecent peptide |
| Biotin-Ahx- | Dansyl-Ahx- | Dabcyl |
| 5-FAM- | Cy3- | Dabcyl / Glu(Edans) -NH2 |
| 5-FAM-Ahx- | Cy5- | Dansyl- |
| FITC- | MCA/DNP | Dansyl-Ahx- |
| FITC-Ahx- | AMC | Edans / Dabcyl |
Peptide Conjugates
| BSA (-COOH of C terminalis | KLH(-NH2 of N terminal) ; | OVA (-COOH of C terminatio) |
| BSA Conjugatio in Cys | KLH Conjugatio in Cys | OVA(-NH2 of N terminal) ; |
| OVA Conjugatio in Cys |
Phosphorylation
| {pSer} | {D-pSer} |
| {pTyr} | {D-pTyr} |
| {pThr} | {D-pThr} |
Aliae modificationes (PEGylation, cyclicas modificationes, pontes solve)
| PEGylation | Cyclic modifications | Pontes disulfide |
| {Min-PEG1} | Caput ad caudam cyclica | {Mono disulfide pontis} |
| {Min-PEG2} | {Pontem Duplex Disulfide} | |
| {PEG-11} | {Triplex pons Disulfide} | |
| {PEG-12} | {Random Disulfide pontem} | |
| ...... | ...... | ...... |